Waleed H. Hassanein - 06 Jan 2022 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
President & CEO, Director
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
06 Jan 2022
Net transactions value
+$34,264
Form type
4
Filing time
07 Jan 2022, 16:00:13 UTC
Next filing
24 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $34,264 +122,371 +30% $0.2800* 526,214 06 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -122,371 -100% $0.000000* 0 06 Jan 2022 Common Stock 122,371 $0.2800 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the reporting person's cash exercise of a stock option.
F2 The option is fully vested.